Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Flux Power Flux Stock Exposed To Global Risks Price At 1.09 Up 0.93 20260404 Vet Stock Poised For Growth Key Support Holds 20260403 1 What Caused Twist Twst Stock To Drop Recently Price At 48.44 Up 1.11 20260413 Can Impact Biomedical Ibo Stock Reach New Highs Price At 0.57 Down 5.56 20260406 Is Omada Health Omda Stock Rebounding Price At 12.88 Up 3.87 20260408 St Joe JOE Company Health St Joe Company The posts 052 EPS 513M revenue on strong Florida demand The key trends fueling VinFast VFSWW growth potential 047 20260508 PINE Alpine shares fall 143 as EPS misses by 216 overshadowing strong 159 revenue growth Should I buy or sell NIQ Global NIQ stock today Q4 2025 EPS Misses Views ProShares Ultra VIX ShortTerm Futures ETF UVXY Included in ProShares November 2025 Batch of 22 Leveraged and Inverse ETF Share Splits The balance sheet strength behind StandardAero SARO results Q1 2026 EPS Misses Views Is MicroCloud HOLOW stock showing strong momentum Smart Money Active 20260420 XAIR Beyond Air Q1 2026 revenue surges 2197 percent year over year shares jump 468 percent Alpha Met AMR Stock Asset Based Valuation Breakout Watch 20260420 Diamondback Energy FANG Assessing Investment Positioning Amid Goldman Sachs HigherForLonger Oil Price Outlook White House Correspondents Dinner 2025 Press Freedom Dynamics Policy Signals and Media Sector Risk What are the risks of Energous Corporation WATT stock Q4 2025 EPS Misses Estimates BIOA BioAge Labs posts narrower Q4 2025 loss than expected shares fall 11 percent today Sypris Solutions SYPR Stock Cheap or Expensive Sypris Solutions posts 002 EPS on steady defense segment performance Brady Corporation Q3 2026 Earnings Call Highlights Strategic Progress in Workplace Safety Markets Pangaea PANL Q1 2026 Earnings EPS 011 Beats Estimates Wilson Sonsini Advises Insider One on Bluecore Acquisition in Marketing Tech Deal Musk vs Altman Trial Billionaire Rivals Clash Over OpenAIs Mission in Court Anduril Secures 5 Billion Funding Round Valuation Soars to 61 Billion Coastal Fin CCB Falls 109 Watching 6550 Support 20260519 Silvercorp SVM Slips 598 Testing 1403 Support 20260514 Blackrock MYN Stock Slides 130 Support at 932 20260515 Hacking Your Brain for Financial and Personal Growth What the Latest Research Suggests Tecogen TGEN Stock Up 218 Key Resistance at 575 20260520 Ocean Power Technologies Inc OPTT Q1 2026 Earnings EPS Miss Widens as Losses Persist Cartesian Therapeutics RNAC Q1 2026 Earnings Soft Quarter Raises Questions MultiCap Portfolio Mix Outperforms Broader Index A Look at Nifty 50 Next 50 Midcap and Smallcap Blend Wall Streets Mixed Sentiment on Nucor What Investors Should Know Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down Ferrari Lear Intuitive Machines Micron Lead Premarket Movers TULP Q4 2014 Earnings EPS Misses Estimates Significantly LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details GLW Q1 2026 Earnings EPS Beat Surprises Amid Disclosed Revenue Uncertainty AMTD IDEA Group Q4 2020 Earnings Strong EPS Beat Amid Revenue Disclosure Gap Heartcore Enterprises Inc HTCR Q2 2025 Earnings Massive EPS Beat Drives DoubleDigit Stock Surge Cantor Equity Partners II Inc CEPT Holds Steady Near Support Amid Low Volatility Revolve Group RVLV Edges Higher Amid Sector Momentum Key Levels to Watch Youlife Group Surges 17 as YOUL Tests Key Resistance at 078 Is DiaMedica DMAC stock worth committing funds to Drifts Higher 20260422 KRUS Kura Sushi posts narrow Q1 2026 EPS beat but shares edge down slightly following earnings release Fidelity D FDBC Stock Employment Data 155 20260420 Palmer PSBD Stock Technical Risk Signals Palmer Logs 1379 EPS Miss Posts 016 Loss Is Southern SOMN stock sensitive to the economy Consolidates 20260420 Artius II AACBR Stock Should You Hold AACBR Earnings Artius II posts no financial results as it seeks deSPAC merger targets Johnson Johnson JNJ Undervalued Pharma Leader Offers Defensive Upside Amid Sector Selloff Jim Cramer Backs Staggered Entry